BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9851971)

  • 1. Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes.
    Holland EC; Hively WP; Gallo V; Varmus HE
    Genes Dev; 1998 Dec; 12(23):3644-9. PubMed ID: 9851971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
    Holland EC; Hively WP; DePinho RA; Varmus HE
    Genes Dev; 1998 Dec; 12(23):3675-85. PubMed ID: 9851974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB
    Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
    Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
    Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
    Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E
    Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.
    Bachoo RM; Maher EA; Ligon KL; Sharpless NE; Chan SS; You MJ; Tang Y; DeFrances J; Stover E; Weissleder R; Rowitch DH; Louis DN; DePinho RA
    Cancer Cell; 2002 Apr; 1(3):269-77. PubMed ID: 12086863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
    Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
    Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo.
    Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI
    Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG
    Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients.
    Soufir N; Daya-Grosjean L; de La Salmonière P ; Moles JP; Dubertret L; Sarasin A; Basset-Seguin N
    J Natl Cancer Inst; 2000 Nov; 92(22):1841-7. PubMed ID: 11078762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.